Drug Shortage Report for VIOKACE
Report ID | 73777 |
Drug Identification Number | 02230019 |
Brand name | VIOKACE |
Common or Proper name | Viokace |
Company Name | NESTLE ENTERPRISES S.A. |
Market Status | MARKETED |
Active Ingredient(s) | AMYLASE PROTEASE LIPASE |
Strength(s) | 56400UNIT 57100UNIT 10440UNIT |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100's count bottle |
ATC code | A09AA |
ATC description | DIGESTIVES, INCL ENZYMES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-02-15 |
Actual start date | |
Estimated end date | 2019-04-19 |
Actual end date | 2019-01-29 |
Shortage status | Avoided shortage |
Updated date | 2019-01-29 |
Company comments | Delay with product release and raw material replenishment. Viokace 10440 will remain available to alleviate impact. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 12, RUE ENTRE-DEUX-VILLES VEVEY, -- SWITZERLAND 1800 |
Company contact information | kfeltmate@apcipharma.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-29 | English | Compare |
v2 | 2019-01-29 | French | Compare |
v3 | 2019-01-29 | English | Compare |
v4 | 2019-01-29 | French | Compare |
Showing 1 to 4 of 4